berberine has been researched along with Intestinal Diseases in 7 studies
Intestinal Diseases: Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study aims to evaluate the effect of berberine-based carbon quantum dots (Ber-CDs) on improving 5-fluorouracil (5-FU)-induced intestinal mucositis in C57BL/6 mice, and explored the mechanisms behind this effect." | 8.31 | Berberine-Based Carbon Quantum Dots Improve Intestinal Barrier Injury and Alleviate Oxidative Stress in C57BL/6 Mice with 5-Fluorouracil-Induced Intestinal Mucositis by Enhancing Gut-Derived Short-Chain Fatty Acids Contents. ( He, J; Li, H; Sun, C; Tan, J; Wang, D; Wu, L; Xi, Y; Yan, M, 2023) |
| "Berberine treatment was found to have no significant effect on the histological changes in the pancreas, but was observed to ameliorate the intestinal mucosal barrier damage and membrane permeability associated with SAP." | 5.40 | Berberine ameliorates severe acute pancreatitis‑induced intestinal barrier dysfunction via a myosin light chain phosphorylation‑dependent pathway. ( Chen, T; Huang, Z; Liang, HY; Tang, LJ; Yan, HT, 2014) |
| "This study aims to evaluate the effect of berberine-based carbon quantum dots (Ber-CDs) on improving 5-fluorouracil (5-FU)-induced intestinal mucositis in C57BL/6 mice, and explored the mechanisms behind this effect." | 4.31 | Berberine-Based Carbon Quantum Dots Improve Intestinal Barrier Injury and Alleviate Oxidative Stress in C57BL/6 Mice with 5-Fluorouracil-Induced Intestinal Mucositis by Enhancing Gut-Derived Short-Chain Fatty Acids Contents. ( He, J; Li, H; Sun, C; Tan, J; Wang, D; Wu, L; Xi, Y; Yan, M, 2023) |
| "Pretreatment with berberine significantly decreased the incidence and severity of RIAIS in patients with abdominal/pelvic radiotherapy when compared with the patients of the control group (P < 0." | 2.75 | Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy. ( Chen, ZT; Hao, P; Hu, YD; Li, DZ; Li, GH; Pu, P; Wan, JQ; Wang, DL; Wang, J; Wang, WD; Xu, XQ; Zhou, YB; Zhu, B, 2010) |
| "Berberine treatment was found to have no significant effect on the histological changes in the pancreas, but was observed to ameliorate the intestinal mucosal barrier damage and membrane permeability associated with SAP." | 1.40 | Berberine ameliorates severe acute pancreatitis‑induced intestinal barrier dysfunction via a myosin light chain phosphorylation‑dependent pathway. ( Chen, T; Huang, Z; Liang, HY; Tang, LJ; Yan, HT, 2014) |
| "Berberine (BBR) has been shown to attenuate the deleterious effects of ischemia/reperfusion (I/R) injury in the brain." | 1.39 | Berberine reduces rat intestinal tight junction injury induced by ischemia-reperfusion associated with the suppression of inducible nitric oxide synthesis. ( Gong, J; Gu, L; Li, J; Li, N; Li, Q; Yu, W; Zhu, W, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y | 1 |
| Hao, Z | 1 |
| Zhao, H | 1 |
| Duan, X | 1 |
| Jia, D | 1 |
| Li, K | 1 |
| Yang, Y | 1 |
| Cui, H | 1 |
| Gao, M | 1 |
| Zhao, D | 1 |
| Wu, L | 1 |
| Xi, Y | 1 |
| Yan, M | 1 |
| Sun, C | 1 |
| Tan, J | 1 |
| He, J | 1 |
| Li, H | 1 |
| Wang, D | 1 |
| Gu, L | 1 |
| Li, N | 1 |
| Yu, W | 1 |
| Gong, J | 1 |
| Li, Q | 1 |
| Zhu, W | 1 |
| Li, J | 2 |
| Liang, HY | 1 |
| Chen, T | 1 |
| Yan, HT | 1 |
| Huang, Z | 1 |
| Tang, LJ | 1 |
| Zhang, Y | 1 |
| Li, X | 1 |
| Zhang, Q | 1 |
| Ju, J | 1 |
| Du, N | 1 |
| Liu, X | 1 |
| Chen, X | 1 |
| Cheng, F | 1 |
| Yang, L | 1 |
| Xu, C | 1 |
| Bilal, MU | 1 |
| Wei, Y | 1 |
| Lu, Y | 1 |
| Yang, B | 1 |
| Watanabe-Fukuda, Y | 1 |
| Yamamoto, M | 1 |
| Miura, N | 1 |
| Fukutake, M | 1 |
| Ishige, A | 1 |
| Yamaguchi, R | 1 |
| Nagasaki, M | 1 |
| Saito, A | 1 |
| Imoto, S | 1 |
| Miyano, S | 1 |
| Takeda, J | 1 |
| Watanabe, K | 1 |
| Li, GH | 1 |
| Wang, DL | 1 |
| Hu, YD | 1 |
| Pu, P | 1 |
| Li, DZ | 1 |
| Wang, WD | 1 |
| Zhu, B | 1 |
| Hao, P | 1 |
| Wang, J | 1 |
| Xu, XQ | 1 |
| Wan, JQ | 1 |
| Zhou, YB | 1 |
| Chen, ZT | 1 |
1 trial available for berberine and Intestinal Diseases
| Article | Year |
|---|---|
Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy.
Topics: Abdomen; Acute Disease; Acute Radiation Syndrome; Berberine; Carcinoma, Squamous Cell; Colitis; Fema | 2010 |
6 other studies available for berberine and Intestinal Diseases
| Article | Year |
|---|---|
Berberine alleviates intestinal barrier dysfunction in glucolipid metabolism disorder hamsters by modulating gut microbiota and gut-microbiota-related tryptophan metabolites.
Topics: Animals; Berberine; Cricetinae; Gastrointestinal Microbiome; Intestinal Diseases; Intestines; Microb | 2023 |
Berberine-Based Carbon Quantum Dots Improve Intestinal Barrier Injury and Alleviate Oxidative Stress in C57BL/6 Mice with 5-Fluorouracil-Induced Intestinal Mucositis by Enhancing Gut-Derived Short-Chain Fatty Acids Contents.
Topics: Animals; Berberine; Fatty Acids, Volatile; Fluorouracil; Intestinal Diseases; Intestinal Mucosa; Mic | 2023 |
Berberine reduces rat intestinal tight junction injury induced by ischemia-reperfusion associated with the suppression of inducible nitric oxide synthesis.
Topics: Animals; Berberine; Disease Models, Animal; Intestinal Diseases; Intestinal Mucosa; Male; Membrane M | 2013 |
Berberine ameliorates severe acute pancreatitis‑induced intestinal barrier dysfunction via a myosin light chain phosphorylation‑dependent pathway.
Topics: Animals; Berberine; Disease Models, Animal; Intestinal Diseases; Intestinal Mucosa; Myosin Light Cha | 2014 |
Berberine hydrochloride prevents postsurgery intestinal adhesion and inflammation in rats.
Topics: Animals; Anti-Inflammatory Agents; Berberine; Disease Models, Animal; Intercellular Adhesion Molecul | 2014 |
Orengedokuto and berberine improve indomethacin-induced small intestinal injury via adenosine.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Adenosine Deaminase; Alkaloids; Animals; Anti-Inflamma | 2009 |